Lee Glavin
Fabio vel iudice vincam, sunt in culpa qui officia. Morbi odio eros, volutpat ut pharetra vitae, lobortis sed nibh. Quid securi etiam tamquam eu fugiat nulla pariatur.
Fabio vel iudice vincam, sunt in culpa qui officia. Morbi odio eros, volutpat ut pharetra vitae, lobortis sed nibh. Quid securi etiam tamquam eu fugiat nulla pariatur.
AACR Annual Meeting 2019: Past, Present, and Future of CDK4/6-targeted Therapeutics
Learn MoreSABCS 2015: Denosumab Improves Outcomes for Patients Taking Aromatase Inhibitors
Learn MorePersonalized Neoantigen Vaccines Boost Progress Against Aggressive Cancers
Learn MoreHow Community Outreach Can Increase Access to Colorectal Cancer Screening in Underserved Populations
Learn MoreA ‘Gutsy’ Approach to Predict Immunotherapy Responses
Learn MoreProgress and Promise Against Cancer: A Biden Cancer Community Event
Learn MoreNew Molecularly Targeted Therapeutic Approved by FDA for Numerous Blood Disorders
Learn MoreApril Editors’ Picks from AACR Journals
Learn MoreCancer Disparities Progress Report Highlights Need to Achieve Equity
Learn MoreCelebrating 75 Years of Publishing Cancer Research
Learn MoreWe have made spectacular progress against cancer thanks to breakthroughs in cancer science. However, with more than 600,000 people in the United States projected to die from cancer this year, our work is not done. Get involved to ensure that the momentum continues: